![]() |
11th International AIDS ConferenceVancouver, British Columbia — July 7-12, 1996 |
Abstract Numbering & Table of ContentsThe abstracts have been given reference numbers as follows:
Mo = Monday, Tu = Tuesday, We = Wednesday, Th = Thursday, Lb = Late-Breaker Print only abstracts. The 2,807 printed only abstracts are identified by their special numbering, which begins with a letter A-G (signifying the track) and is followed by a 5 digit number. Tracks This track will highlight all aspects related to HIV structure and replication and its regulation as well as host immune responses. Drug discovery, research on vaccines and development of animal models will also be addressed. This track will be of particular interest to laboratory researchers and clinicians involved in basic principles of HIV. This track will highlight the characteristics and clinical course of HIV infection and related diseases, the evaluation of diagnostic and therapeutic tools, including resistance tests, and the clinical trials and cohort studies which provide the scientific basis for therapeutic interventions and care. This track will be of particular interest to investigators and clinicians participating in clinical research related to HIV-1 infection. Track C: Epidemiology and Public Health This track will highlight the description and dynamics of the evolving HIV/AIDS epidemic, the natural history and the burden and impact of HIV infection in the world. Presentations in this track will be based on both observational and experimental studies, as well as on surveillance methods. This track will be of particular interest to public health professionals, academic researchers in epidemiology or related areas, and people using epidemiologic parameters in support of HIV/AIDS programs and policies. Track D: Social Science, Research, Policy and Action This track will highlight the design, testing and evaluation of HIV preventive interventions for both HIV- and HIV+ persons, including those interventions addressing early diagnosis, co-factors, and risk and harm reduction. This track will also address methodological and ethical issues in HIV prevention research. This track will be of particular interest to those involved in advancing multidisciplinary (biomedical, behavioral, and social sciences) investigations of HIV prevention. |
Cite as: Int Conf AIDS. 1996 Jul 7-12;11:Abstract No. xx